PLX compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

PLXProtalix BioTherapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

PLXProtalix BioTherapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PLX 6

PFEPfizercustomer

—Chiesiunlistedsupplier

—New Zealand Clinical Research (NZCR)unlistedsupplier

—Secarnaunlistedsupplier

2 more · PLX chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

PLXProtalix BioTherapeutics, Inc.

2.53▲+0.77%· post 2.53· delayed

Mkt cap$202.2MRevenue$20MQ2 FY26Revenue$53MFY25

AMGNAmgen Inc

460.55▲+0.06%· post 460.25· delayed

After hoursNov 6 '26delayed

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

After hoursNov 6 '26delayed

PLXProtalix BioTherapeutics, Inc.

AMGNAmgen Inc

2.53▲+0.77%post 2.53delayed

Price

460.55▲+0.06%post 460.25delayed

$202.2M

Mkt cap

$249.0B

Q2 FY26$20M

Revenue

$10.4BQ3 FY26

FY25$53M

Revenue

$36.8BFY25

PLX2.53▲+0.77%vsAMGN460.55▲+0.06%After hoursNov 6 '26delayed